![Li Malmberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Li Malmberg is a professional who has held several positions in the biotechnology industry.
She was the Director & Head-Process Sciences at AbbVie, Inc., the VP-Biologics Development & Manufacturing at Celgene Corp., the Chief Technology & Manufacturing Officer at Xilio Therapeutics, Inc., and the Senior Vice President-CMC at Magenta Therapeutics, Inc. Malmberg received her undergraduate degree from the University of Illinois and her doctorate from the University of Minnesota Twin Cities.
| Empresas | Cargo | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| XILIO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
| ABBVIE INC. | Corporate Officer/Principal | - |
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota Twin Cities
 University of Minnesota Twin Cities Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
